Form 4 for ABUS Arbutus Biopharma Corp
Accepted 2026-09-23 20:31:17 ET · period of report 2026-09-18 · accession 0001447028-26-000051 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-09-23 20:31 | 2026-09-18 | ABUS | Sawhney Roger | Dir | M - OptEx | $3.88 | +131.3K | 131.3K | New | +$509.6K |
| D | 2026-09-23 20:31 | 2026-09-18 | ABUS | Sawhney Roger | Dir | F - Tax | $5.07 | -100.5K | 30.8K | -77% | -$509.6K |
| DM | 2026-09-23 20:31 | 2026-09-18 | ABUS | Sawhney Roger | Dir | M - OptEx | $0.00 | -131.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2026-09-18 | M | A | 52,533 | $3.34 | 52,533 | D | — | — | |
| 2 | Common | Common Shares | 2026-09-18 | M | A | 78,800 | $4.24 | 131,333 | D | — | — | |
| 3 | Common | Common Shares | 2026-09-18 | F | D | 100,508 | $5.07 | 30,825 | D | — | — | (F1) The Reporting Person exercised options on September 18, 2026. The Issuer withheld an aggregate of 100,508 shares otherwise issuable upon the exercises to satisfy the aggregate exercise prices. |
| 4 | Derivative | Stock Option (Right to Buy) | 2026-09-18 | M | D | 52,533 | $0.00 | 105,067 | D | $3.34 · — to 2035-08-04 | 52,533 Common Shares | (F2) The option, representing a right to purchase a total of 157,600 shares, vests over a three-year period, with 1/3rd of the total shares subject to the option vesting at each of the 1st, 2nd and 3rd anniversaries of the August 4, 2025 grant date, subject to the Reporting Person's continuous service as of each vesting date. |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-09-18 | M | D | 78,800 | $0.00 | 0 | D | $4.24 · 2026-06-08 to 2036-06-08 | 78,800 Common Shares | (F3) The option, representing a right to purchase a total of 78,800 shares, was fully vested and exercisable as of the June 8, 2026 grant date. |